News | Artificial Intelligence | June 13, 2018

Wake Radiology Launches First Installation of EnvoyAI Platform

Platform provides access to over 53 artificial intelligence engines that may be applied to medical imaging studies

Wake Radiology Launches First Installation of EnvoyAI Platform

June 13, 2018 — Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation at Wake Radiology in Raleigh, N.C. Wake Radiology is using the platform to provide physicians access to EnvoyAI’s growing marketplace of over 53 AI engines that may be applied to their medical imaging studies. Wake Radiology selected EnvoyAI as the fastest and most comprehensive means to achieving a complete AI strategy for the diverse breadth of clinical services that it provides for patients and referring physicians.

With nearly 50 radiologists, Wake Radiology is now able to experiment with scores of new technologies and has already brought five of the imaging processing engines to pre-production status, with reportedly excellent performance and results. “We realize that AI has great potential to improve healthcare by increasing our efficiency and efficacy as providers. It is important that we embrace the technology early to maximize its effect in our practice and in the lives of our patients. Implementing EnvoyAI gives our physicians an easy and integrated way to begin interacting with the wide variety of algorithms available on the EnvoyAI Exchange from directly within the PACS [picture archiving and communication system] environment. Our radiologists can experiment and immediately apply algorithms that impact their workflow and patient care.” shared Chief Medical Officer William Way, M.D., of Wake Radiology.  

Wake Radiology Chief Information Officer Matt Dewey said, “Wake Radiology has very stringent security requirements. What would have otherwise been a multitude of unacceptable implementation and security challenges resulting from purchasing algorithms separately, has been simplified into a single turn-key platform. We were very impressed with the depth of thought and creativity that went into designing the EnvoyAI security and workflow features. The implementation was seamless and the technical support has been fantastic.”

EnvoyAI said that this initial commercial implementation will be followed quickly by many others around the U.S., which are already underway.  

The company demonstrated the EnvoyAI platform at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, May 31-June 2 in National Harbor, Md.

For more information: www.envoyai.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
Sponsored Content | Videos | Artificial Intelligence | February 07, 2020
At RSNA19, GE Healthcare introduced its...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Infervision’s deep learning medical imaging platform is helping screen patients for the coronavirus in China. It acts as second pair of eyes to identify multiple diseases from one set of chest scans. The artificial intelligence (AI) can provide a complete view of the nodule, including volume and density.

Infervision’s deep learning medical imaging platform is helping screen patients for the coronavirus in China. It acts as second pair of eyes to identify multiple diseases from one set of chest scans. The artificial intelligence (AI) can provide a complete view of the nodule, including volume and density.

News | Artificial Intelligence | February 04, 2020
February 4, 2020 — Since January 2020, the...